Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze

NCT00634504 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma
Leukemia
Lymphoma

Interventions

DRUG: glucarpidase, high-dose methotrexate, leucovorin
DRUG: high-dose methotrexate, leucovorin

Sponsor

BTG International Inc.